Drug Shortage Report for CLAVULIN 400
| Report ID | 110855 |
| Drug Identification Number | 02238830 |
| Brand name | CLAVULIN 400 |
| Common or Proper name | amoxicillin / clavulanate potassium for oral suspension |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CLAVULANIC ACID AMOXICILLIN |
| Strength(s) | 57MG 400MG |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 70mL |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2020-04-01 |
| Estimated end date | Unknown |
| Actual end date | 2020-06-01 |
| Shortage status | Resolved |
| Updated date | 2020-06-03 |
| Company comments | Re-supply is ongoing with inventory allocated to 100% of regular demand. |
| Health Canada comments | |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.